Philip Kumanov

1.6k total citations
39 papers, 739 citations indexed

About

Philip Kumanov is a scholar working on Reproductive Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Philip Kumanov has authored 39 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Reproductive Medicine, 15 papers in Endocrinology, Diabetes and Metabolism and 13 papers in Molecular Biology. Recurrent topics in Philip Kumanov's work include Sexual Differentiation and Disorders (11 papers), Hormonal and reproductive studies (11 papers) and Ovarian function and disorders (8 papers). Philip Kumanov is often cited by papers focused on Sexual Differentiation and Disorders (11 papers), Hormonal and reproductive studies (11 papers) and Ovarian function and disorders (8 papers). Philip Kumanov collaborates with scholars based in Bulgaria, United States and Germany. Philip Kumanov's co-authors include Analia Tomova, Ralitsa Robeva, Ashok Agarwal, Kalyana Nandipati, Georgi Кirilov, Fnu Deepinder, Jianbo Li, Sushil Prabakaran, Jochen Schopohl and Georg Brabant and has published in prestigious journals such as SHILAP Revista de lepidopterología, PEDIATRICS and Fertility and Sterility.

In The Last Decade

Philip Kumanov

36 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Kumanov Bulgaria 16 328 246 178 164 92 39 739
Analia Tomova Bulgaria 16 316 1.0× 208 0.8× 262 1.5× 160 1.0× 69 0.8× 44 822
Ralitsa Robeva Bulgaria 16 225 0.7× 371 1.5× 205 1.2× 123 0.8× 169 1.8× 53 893
Sebastián Carranza‐Lira Mexico 17 309 0.9× 126 0.5× 212 1.2× 267 1.6× 172 1.9× 93 872
Anne Kirstine Bang Denmark 17 460 1.4× 251 1.0× 170 1.0× 318 1.9× 86 0.9× 32 932
Valentinas Matulevičius Lithuania 12 378 1.2× 197 0.8× 85 0.5× 164 1.0× 98 1.1× 16 562
Juan Pablo Méndez Mexico 21 433 1.3× 565 2.3× 281 1.6× 211 1.3× 368 4.0× 78 1.2k
Anne‐Maarit Haavisto Finland 9 249 0.8× 245 1.0× 122 0.7× 117 0.7× 107 1.2× 12 636
Maria G. Vogiatzi United States 13 189 0.6× 189 0.8× 124 0.7× 141 0.9× 106 1.2× 33 582
Svetlana Vujović Serbia 14 234 0.7× 136 0.6× 180 1.0× 312 1.9× 140 1.5× 43 759
Courtney Marsh United States 15 269 0.8× 238 1.0× 65 0.4× 140 0.9× 79 0.9× 40 693

Countries citing papers authored by Philip Kumanov

Since Specialization
Citations

This map shows the geographic impact of Philip Kumanov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Kumanov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Kumanov more than expected).

Fields of papers citing papers by Philip Kumanov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Kumanov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Kumanov. The network helps show where Philip Kumanov may publish in the future.

Co-authorship network of co-authors of Philip Kumanov

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Kumanov. A scholar is included among the top collaborators of Philip Kumanov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Kumanov. Philip Kumanov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumanov, Philip, et al.. (2025). Kisspeptin system–physiology and clinical perspectives. Annales d Endocrinologie. 86(4). 101793–101793.
2.
Nordio, Maurizio, et al.. (2021). d-Chiro-Inositol improves testosterone levels in older hypogonadal men with low-normal testosterone: a pilot study. Basic and Clinical Andrology. 31(1). 28–28. 5 indexed citations
3.
Robeva, Ralitsa, Radoslava Vazharova, Susanne Ledig, et al.. (2017). New Territory for an Old Disease: 5-Alpha-Reductase Type 2 Deficiency in Bulgaria. Sexual Development. 11(1). 21–28. 8 indexed citations
4.
Savov, Alexey, et al.. (2014). [PAL-1 5G/4G polymorphism in patients with systemic lupus erythematosus].. PubMed. 53(7). 13–7.
5.
Robeva, Ralitsa & Philip Kumanov. (2013). Sperm disturbances in metabolic syndrome: what we actually know. Expert Review of Endocrinology & Metabolism. 8(4). 351–353. 1 indexed citations
6.
Robeva, Ralitsa, Georgi Кirilov, Alexey Savov, et al.. (2013). Androgen receptor (CAG)n polymorphism and androgen levels in women with systemic lupus erythematosus and healthy controls. Rheumatology International. 33(8). 2031–2038. 14 indexed citations
7.
Robeva, Ralitsa, Yavor Assyov, Analia Tomova, & Philip Kumanov. (2012). Acne vulgaris is associated with intensive pubertal development and altitude of residence—a cross-sectional population-based study on 6,200 boys. European Journal of Pediatrics. 172(4). 465–471. 7 indexed citations
8.
Robeva, Ralitsa, Analia Tomova, Georgi Кirilov, & Philip Kumanov. (2011). Anti-Müllerian hormone and inhibin B levels reflect altered Sertoli cell function in men with metabolic syndrome. Andrologia. 44. 329–334. 33 indexed citations
9.
Tomova, Analia, et al.. (2010). Growth and Development of Male External Genitalia. Archives of Pediatrics and Adolescent Medicine. 164(12). 1152–7. 61 indexed citations
10.
Tomova, Analia, et al.. (2008). Anti-Mullerian hormone levels in women with polycystic ovary syndrome before and after metformin therapy. 3 indexed citations
11.
Kumanov, Philip, Fnu Deepinder, Ralitsa Robeva, et al.. (2007). Relationship of Adolescent Gynecomastia with Varicocele and Somatometric Parameters: A Cross-Sectional Study in 6200 Healthy Boys. Journal of Adolescent Health. 41(2). 126–131. 52 indexed citations
12.
Kumanov, Philip, Ralitsa Robeva, & Analia Tomova. (2007). Prevalence of Micropenis Among Boys from Different Regions of Bulgaria. Journal of Pediatric Endocrinology and Metabolism. 20(7). 791–5. 5 indexed citations
13.
Kumanov, Philip, Analia Tomova, Ralitsa Robeva, & Georgi Кirilov. (2007). Influence of ageing and some lifestyle factors on male gonadal function: a study in Bulgaria. Andrologia. 39(4). 136–140. 4 indexed citations
14.
Robeva, Ralitsa, Georgi Кirilov, Analia Tomova, & Philip Kumanov. (2006). Low testosterone levels and unimpaired melatonin secretion in young males with metabolic syndrome. Andrologia. 38(6). 216–220. 21 indexed citations
15.
Kumanov, Philip, Analia Tomova, & Georgi Кirilov. (2006). Testosterone replacement therapy in male hypogonadism is not associated with increase of endothelin‐1 levels. International Journal of Andrology. 30(1). 41–47. 26 indexed citations
16.
Kumanov, Philip, et al.. (2006). Prevalence of the hypospadias among Bulgarian boys – a prospective study. European Journal of Pediatrics. 166(9). 987–988. 5 indexed citations
17.
Prabakaran, Sushil, et al.. (2006). Adolescent Varicocele: Association with Somatometric Parameters. Urologia Internationalis. 77(2). 114–117. 35 indexed citations
18.
Kumanov, Philip, et al.. (2005). Significance of inhibin in reproductive pathophysiology and current clinical applications. Reproductive BioMedicine Online. 10(6). 786–796. 29 indexed citations
19.
Tomova, Analia & Philip Kumanov. (2004). Are dehydroepiandrosterone sulphate and lipids associated with erectile dysfunction?. Maturitas. 50(4). 294–299. 5 indexed citations
20.
Tomova, Analia, et al.. (2000). The influence of hyperthyroidism on the hypothalamic-pituitary-gonadal axis. Experimental and Clinical Endocrinology & Diabetes. 108(4). 282–289. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026